Clearance Summary
SERAFLO ARTERIAL AND VENOUS BLOODLINE SETS received FDA 510(k) clearance under submission number K913526, sponsored by Althin Medical AB an Affiliate of Baxter Intl. The device was reviewed via the Traditional premarket notification pathway and assigned to the Gastroenterology, Urology review panel. The statutory decision date of record is 1991-11-01.
- Submission: K913526
- Applicant / Sponsor: Althin Medical AB an Affiliate of Baxter Intl
- Clearance pathway: Traditional
- Review panel: Gastroenterology, Urology
- Device class: Class II
- Regulation citation: 21 CFR 876.5820
- Decision date: 1991-11-01
Classification & Regulation
This clearance is catalogued under FDA product code FJK and 21 CFR 876.5820, within the Gastroenterology, Urology review panel as a Class II device.